Vicarious Surgical Inc. (RBOT)
NYSE NYSE Primary Summary
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript
Vicarious Surgical Inc. ( RBOT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Stephen From - CEO & Director Sarah Romano - CFO & Treasurer Conference Call Participants Marissa Bych - Gilmartin Group LLC Joshua Jennings - TD Cowen, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Third Quarter Earnings Call.
Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants Adam David Sachs - Co-Founder, President & Director Sarah Romano - CFO & Treasurer Stephen From - CEO & Director Conference Call Participants Adam Carl Maeder - Piper Sandler & Co., Research Division Eric Evan Anderson - TD Cowen, Research Division Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Marissa Elizabeth Bych - Gilmartin Group LLC Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Second Quarter Earnings Call.
Vicarious Surgical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 22 | $129 | $1.67 | -$127.33 | -98.71% |
Vicarious Surgical Inc. (RBOT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Vicarious Surgical Inc. ever had a stock split?
Vicarious Surgical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Stephen From CEO | NYSE Exchange | 92561V208 CUSIP |
| US Country | 48 Employees | - Last Dividend | 13 Jun 2024 Last Split | 4 Sep 2020 IPO Date |
Overview
Vicarious Surgical Inc. represents a pioneering force in the healthcare technology sector, specializing in the development and sale of advanced surgical robots within the United States. Founded in 2014 and headquartered in Waltham, Massachusetts, this innovative company has positioned itself at the forefront of minimally invasive surgical solutions. Vicarious Surgical Inc. leverages cutting-edge robotics to enhance the capabilities of surgeons, ultimately aiming to improve patient outcomes and redefine standards within surgical practices.
Products and Services
- Vicarious Surgical System
This flagship product by Vicarious Surgical Inc. stands as a testament to the company's innovative spirit and engineering prowess. The Vicarious Surgical System is a sophisticated single-port surgical robot designed to virtually transport surgeons inside the patient. Through this unique approach, the system allows for precision-guided minimally invasive surgery, significantly reducing recovery times and potential complications associated with traditional surgical methods. The agility and flexibility of the robotic platform enable a range of complex procedures to be performed with enhanced control and visibility, marking a significant leap forward in surgical technology.
